Trade Summary

6 days ago, Ticho Barry, serving as Chief Medical Officer at Stoke Therapeutics, Inc. (STOK), sold 14,311 shares at $31.92 per share, for a total transaction value of $456,835.00. Following this transaction, Ticho Barry now holds 40,702 shares of STOK.

This sale represents a 26.00% decrease in Ticho Barry's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 19, 2026, 2 days after the trade was made.

Stoke Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.